David Montani

1994–2025 年に発表

222
論文数
31,830
被引用数
94
h 指数
208
i10 指数

被引用数

David Montani の年別被引用数1993 年: 被引用 1 件1995 年: 被引用 5 件1996 年: 被引用 1 件1997 年: 被引用 8 件1998 年: 被引用 4 件1999 年: 被引用 4 件2000 年: 被引用 3 件2001 年: 被引用 3 件2002 年: 被引用 3 件2003 年: 被引用 7 件2004 年: 被引用 6 件2005 年: 被引用 1 件2006 年: 被引用 1 件2007 年: 被引用 4 件2008 年: 被引用 12 件2009 年: 被引用 48 件2010 年: 被引用 58 件2011 年: 被引用 82 件2012 年: 被引用 145 件2013 年: 被引用 219 件2014 年: 被引用 196 件2015 年: 被引用 188 件2016 年: 被引用 228 件2017 年: 被引用 193 件2018 年: 被引用 264 件2019 年: 被引用 847 件2020 年: 被引用 1,305 件2021 年: 被引用 1,584 件2022 年: 被引用 1,429 件2023 年: 被引用 819 件2024 年: 被引用 1,547 件2025 年: 被引用 659 件2026 年: 被引用 17 件1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,296 件、この内訳の 22%中国: 引用元論文 896 件、この内訳の 8.6%イギリス: 引用元論文 841 件、この内訳の 8.1%フランス: 引用元論文 752 件、この内訳の 7.2%ドイツ: 引用元論文 689 件、この内訳の 6.6%イタリア: 引用元論文 492 件、この内訳の 4.7%カナダ: 引用元論文 445 件、この内訳の 4.3%オランダ: 引用元論文 351 件、この内訳の 3.4%スペイン: 引用元論文 287 件、この内訳の 2.7%日本: 引用元論文 279 件、この内訳の 2.7%オーストラリア: 引用元論文 243 件、この内訳の 2.3%ベルギー: 引用元論文 235 件、この内訳の 2.2%
0%22%その他 25.2%

分野

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Engineering2.5%
  • Immunology and Microbiology1.7%
  • Neuroscience0.7%
  • Computer Science0.3%
  • その他1.8%

トピック

  • Pulmonary Hypertension Research and Treatments17.7%
  • COVID-19 Clinical Research Studies3.9%
  • Long-Term Effects of COVID-193.8%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis3.6%
  • Cardiovascular Function and Risk Factors3.2%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.6%
  • その他65.2%

共著者

全論文

検索で開く
  1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

    著者: , , , , , , , - European Respiratory Journal 2018 被引用: 3,806

  2. Sotatercept for the Treatment of Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 585

  3. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

    著者: , , , , , , , , , , , , , , , , - European Respiratory Journal 2022 被引用: 145

  4. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

    著者: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2021 被引用: 198

  5. Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    著者: , , , , , , , , , , , , , , , , , , , , , - Circulation 2010 被引用: 1,387

  6. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2017 被引用: 700

  7. Definition, classification and diagnosis of pulmonary hypertension

    著者: , , , , , , , - European Respiratory Journal 2024 被引用: 371

  8. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raymond L. Benza, Nitin Bhatt, Harm Jan Bogaard, Charles D. Burger, Murali M. Chakinala, Colin Church, Gerry Coghlan, Robin Condliffe, Paul A. Corris, Cesare Danesino, Stéphanie Debette, C. Gregory Elliott, Jean Elwing, Mélanie Eyries, Terry Fortin, André Franke, Robert P. Frantz, Adaani Frost, Joe G. N. Garcia, Stefano Ghio, Hossein-Ardeschir Ghofrani, J. Simon R. Gibbs, John B. Harley, Hua He, Nicholas S. Hill, Russel Hirsch, Arjan C. Houweling, Luke Howard, D. Dunbar Ivy, David G. Kiely, James R. Klinger, Gábor Kovács, Tim Lahm, Matthias Laudes, Rajiv D. Machado, Robert V. MacKenzie Ross, Keith Marsolo, Lisa J. Martin, Shahin Moledina, David Montani, Steven D. Nathan, Michael Newnham, Andrea Olschewski, Horst Olschewski, Ronald J. Oudiz, Willem H. Ouwehand, Andrew J. Peacock, Joanna Pepke‐Żaba, Zia Ur Rehman, Ivan M. Robbins, Dan M. Roden, Erika B. Rosenzweig, Ghulam Saydain, Laura Scelsi, Robert Schilz, Werner Seeger, Christian M. Shaffer, Robert W. Simms, Marc A. Simon, Olivier Sitbon, Jay Suntharalingam, Haiyang Tang, Alexander Tchourbanov, Thenappan Thenappan, Fernando Torres, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, Quinten Waisfisz, Anna K. Walsworth ほか 18 名 - The Lancet Respiratory Medicine 2018 被引用: 213

  9. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 被引用: 451

  10. Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Poubeau, Grégoire Prévôt, Sébastien Renard, Martine Reynaud‐Gaubert, Marianne Riou, P. Roblot, Olivier Sanchez, Andrei Seferian, Cécile Tromeur, Jason Weatherald, Gérald Simonneau, David Montani, Marc Humbert, Olivier Sitbon - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 197

  11. Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2022 被引用: 226

  12. Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ofer Nativ, Zaher Bahouth, Dayou Shi, Wei Zhang, Qingling Hua, Yue-yin Pan, Tao Li, Hu Liu, Amir Karban, Eduard Koifman, Tova Rainis, Roberts Škapars, Armands Sīviņš, Guntis Ancāns, Inta Liepniece‐Karele, Ilze Ķikuste, Ieva Lašina, Ivars Tolmanis, Douglas Johnson, Stuart Z. Millstone, Jennifer A. Fulton, John W. Wells, L HABELSON WILF, Marc Humbert, Mārcis Leja, Nir Peled, Hossam Haick - ACS Nano 2016 被引用: 496

  13. Post-acute COVID-19 syndrome

    著者: , , , , , , , , , , , , , , , - European Respiratory Review 2022 被引用: 268

  14. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management

    著者: , , , , , , , - The Lancet Respiratory Medicine 2023 被引用: 119

  15. Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning

    著者: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 101

  16. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Girerd, Arjan C. Houweling, Luke Howard, Marc Humbert, David G. Kiely, Gábor Kovács, Robert V. MacKenzie Ross, Shahin Moledina, David Montani, Michael Newnham, Andrea Olschewski, Horst Olschewski, Andrew J. Peacock, Joanna Pepke‐Żaba, Inga Prokopenko, Christopher J. Rhodes, Laura Scelsi, Werner Seeger, Florent Soubrier, Dan F. Stein, Jay Suntharalingam, Emilia M. Swietlik, Mark Toshner, David A. van Heel, Anton Vonk Noordegraaf, Quinten Waisfisz, John Wharton, Stephen J. Wort, Willem H. Ouwehand, Nicole Soranzo, Allan Lawrie, Paul D. Upton, Martin R. Wilkins, Richard C. Trembath, Nicholas W. Morrell - Nature Communications 2018 被引用: 384

  17. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , , , - Circulation 2023 被引用: 71

  18. Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

    著者: , , , , , , , , , , , , , , , , , , , , , - Circulation 2012 被引用: 650

  19. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaquelina O. Arakaki, G. Meyer, Rogério Souza, David Langleben, Hikmet Al‐Hiti, Pavel Jansa, Søren Mellemkjær, Fabrice Bauer, David Montani, Gérald Simonneau, Daniel Drömann, H-A Ghofrani, Ekkehard Grünig, Michael Halank, Matthias Held, Marius M. Hoeper, Hans Klose, Nikolaus Kneidinger, Hanno Leuchte, Christian Opitz, Stephan Rosenkranz, Heinrike Wilkens, Hubert Wirtz, Haralampos Karvounis, Georgia Pitsiou, Stylianos E. Orfanos, Michael D’Alto, Stefano Ghio, CD Vizza, Patrizio Vitulo, T. Nakayama, Hisataka Maki, Shunsuke Tatebe, Manuel Ibarra, Tomás Pulido, Arie P.J. van Dijk, Anton Vonk Noordegraaf, Tomasz Roleder, G. Castro, MJ Loureiro, Susana Robalo-Martins, Joan Albert Barberà, M Lázaro, GM Perez-Penate, Antonio Román, C-C Cheng, C-H. Hsu, H-H Hsu, Erhan Atahan, N Mogulkoc Bishop, NG Okumus, Zeynep Pınar Önen, Chang Hj, S-A Chang, Jin Sun Lee, H-K Kim, JG Coghlan, PA Corris, Colin Church, Robin Condliffe, J. Simon R. Gibbs, AJ Peacock, Stephen J. Wort, Roblee P. Allen, Samuel A. Allen, Rana Awdish, RL Benza, Shilpa A. DeSouza, Jeremy Feldman, Shilpa Johri ほか 12 名 - The Lancet Respiratory Medicine 2021 被引用: 161

  20. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , - Circulation Research 2022 被引用: 76

  21. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2021 被引用: 628

  22. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

    著者: , , , , , , , , , , , , , , , - European Respiratory Journal 2019 被引用: 281

  23. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2017 被引用: 165

  24. Pulmonary veno-occlusive disease

    著者: , , , , , , , , , , , , , , - European Respiratory Journal 2016 被引用: 512